Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Huang

Showing results (11-20 of 278) with videos related to

Pageof 28
Sort By:
Clinical Pharmacology and Therapeutics|April 20, 2012
The many sides of off-label prescribingR S Epstein, S-M Huang
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiationP M Harari, S M Huang
Clinical Pharmacology and Therapeutics|January 23, 2013
Drug shortages in the United States: a critical evaluation of root causes and the need for actionD K Gupta, S-M Huang
Seminars in Radiation Oncology|October 26, 2001
Radiation response modification following molecular inhibition of epidermal growth factor receptor signalingP M Harari, S M Huang
Journal of Chromatography|October 29, 1993
High-performance liquid chromatographic determination of a potent AII receptor antagonist (DMP 811) in plasmaA M Agra, S M Huang
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|September 9, 2017
[Interpretation of evidence-based guideline for diagnosis and treatment of Henoch-Schonlein prupura nephritis 2016]C H Zhu, S M Huang
Clinical Pharmacology and Therapeutics|October 22, 2009
Nephropharmacology: drugs and the kidneyA J Atkinson, S-M Huang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Modulation of molecular targets to enhance radiationP M Harari, S M Huang
Clinical Pharmacology and Therapeutics|February 21, 2012
Regulatory science and the role of the regulator in biomedical innovationP K Honig, S-M Huang
Journal of Chromatography|December 25, 1987
High-performance liquid chromatographic determination of a new H2 blocker (ORF 17 910) in plasmaS M Huang, H Tran-Phan
Pageof 28

Showing results (11-20 of 278) with videos related to

Sort By:
Pageof 28
Clinical Pharmacology and Therapeutics|April 20, 2012
The many sides of off-label prescribingR S Epstein, S-M Huang
International Journal of Radiation Oncology, Biology, Physics|February 15, 2001
Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiationP M Harari, S M Huang
Clinical Pharmacology and Therapeutics|January 23, 2013
Drug shortages in the United States: a critical evaluation of root causes and the need for actionD K Gupta, S-M Huang
Seminars in Radiation Oncology|October 26, 2001
Radiation response modification following molecular inhibition of epidermal growth factor receptor signalingP M Harari, S M Huang
Journal of Chromatography|October 29, 1993
High-performance liquid chromatographic determination of a potent AII receptor antagonist (DMP 811) in plasmaA M Agra, S M Huang
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|September 9, 2017
[Interpretation of evidence-based guideline for diagnosis and treatment of Henoch-Schonlein prupura nephritis 2016]C H Zhu, S M Huang
Clinical Pharmacology and Therapeutics|October 22, 2009
Nephropharmacology: drugs and the kidneyA J Atkinson, S-M Huang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Modulation of molecular targets to enhance radiationP M Harari, S M Huang
Clinical Pharmacology and Therapeutics|February 21, 2012
Regulatory science and the role of the regulator in biomedical innovationP K Honig, S-M Huang
Journal of Chromatography|December 25, 1987
High-performance liquid chromatographic determination of a new H2 blocker (ORF 17 910) in plasmaS M Huang, H Tran-Phan
Pageof 28